OFI Advisors’s Edwards Lifesciences EW Stock Holding History

OFI Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$211K	Sell	8,916 -1,812	-17%	-$43.7K	0.01%	1181
2015 Q2	$255K	Buy	10,728 +204	+2%	+$4.6K	0.02%	1131
2015 Q1	$250K	Sell	10,524 -276	-3%	-$6.19K	0.01%	1133
2014 Q4	$229K	Buy	10,800 +1,056	+11%	+$21.2K	0.01%	1132
2014 Q3	$166K	Sell	9,744 -1,596	-14%	-$25.2K	0.01%	1254
2014 Q2	$162K	Sell	11,340 -498	-4%	-$6.75K	0.01%	1270
2014 Q1	$146K	Sell	11,838 -1,464	-11%	-$16.9K	0.01%	1271
2013 Q4	$146K	Buy	13,302 +2,784	+26%	+$31.4K	0.01%	1248
2013 Q3	$122K	Buy	10,518 +1,302	+14%	+$15.2K	0.01%	1230
2013 Q2	$103K	Buy	+9,216	New	+$109K	0.01%	1250

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

OFI Advisors's EW Position: Q3 2015 in Review

OFI Advisors reduced its Edwards Lifesciences (EW) stake by 17% in Q3 2015, selling an estimated $43.7K and leaving 8,916 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #1181.

OFI Advisors first reported a position in EW in Q2 2013 and has held it in 10 quarters since. The position peaked at $255K in Q2 2015. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

OFI Advisors held 8,916 shares of Edwards Lifesciences worth $211K as of Q3 2015.
OFI Advisors sold 1,812 Edwards Lifesciences shares in Q3 2015, an estimated $43.7K.
Edwards Lifesciences made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1181 holding.
OFI Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Edwards Lifesciences position peaked at $255K in Q2 2015.
569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.